Depth of heart, depth of care – June 2026
Advancing Cardiac Care
A Reliable assessment of right ventricular (RV) function remains central to the long-term management of patients with congenital heart disease (CHD).
While cardiac MRI provides the gold standard for volumetric analysis, echocardiography plays an essential role in routine follow-up, particularly between MRI studies.
The challenge is not simply acquiring measurements, but ensuring they are
consistent, repeatable, and comparable over time.
As clinical pathways increasingly rely on longitudinal data, even small variations in how RV measurements are derived can influence the interpretation of change.
The PLUS of VMS+
Serial Monitoring of the Right Ventricle: Insights from AEPC 2026
At AEPC 2026, this challenge was explored through a simple real-world exercise examining how key RV landmarks are identified in practice.
The findings reinforce a broader clinical need:
reliable serial monitoring that reflects true physiological change,
rather than variation in measurement approach.
Study Overview
- 8 delegates participated
- Standard apical four-chamber (A4C) end-diastolic frame used
- Participants independently marked:
- Septal tricuspid annulus
- Lateral tricuspid annulus
- Landmark coordinates analysed and compared to VMS+ AI-assisted placement
This exercise reflects real-world practice, where measurements vary across operators and timepoints.
Key Findings
Clinically reasonable variation was observed
- Septal annulus
- Mean variation: 0.61 mm
- Broader spread
- Lateral annulus
- Mean variation: 0.26 mm
- Tighter clustering
All placements were within a clinically acceptable range, reflecting typical expert interpretation.
These findings align with published evidence showing measurable inter-observer variation even among experienced clinicians.
In contrast, VMS+ produced identical landmark placement for identical input images.
Clinical interpretation
Small differences in landmark placement are expected, even among experienced clinicians.
In this exercise, variation was at the lower end of reported ranges,
reflecting both participant expertise and controlled conditions.
However, even under these conditions, interpretation introduced measurable variability.
In serial monitoring, this can influence comparability between studies, particularly across:
- Different operators
- Different visits
- Different timepoints
Why This Matters
Clinical decisions in pediatric CHD depend on detecting true physiological change, not variation in measurement.
Echocardiography is essential for routine follow-up, but consistency is critical for meaningful longitudinal assessment.
VMS+ addresses this by:
- Providing AI-assisted landmark placement
- Ensuring repeatable, deterministic outputs
- Enabling consistent volumetric reconstruction
By standardising inputs, VMS+ supports more reliable
serial RV monitoring between MRI studies,
improving confidence in longitudinal follow-up.
Tech+
Enhancing Serial RV Monitoring Through Consistent Landmark Placement
Each month, our engineering team highlights one aspect of VMS+’s expanding capabilities.
This month: AI-assisted landmark placement
Challenge
Serial RV monitoring requires measurements that are consistent over time.
In practice, small differences in landmark placement — even among experienced clinicians — introduce variability when comparing studies.
Solution
VMS+ uses AI-assisted landmark placement, trained on expert datasets, to consistently identify key RV structures.
Given the same input image, landmark placement is identical every time, reducing variability at the point of measurement.
Benefits
- Repeatable results
Same input → same output - Improved comparability
More reliable tracking of RV volumes and EF - Reduced variation at source
Less dependence on manual interpretation - Aligned with clinical workflow
Supports follow-up between MRI assessments
Community Spotlight
Supporting CHD Teams Beyond the Scan
Our clinical and research partners continue to shape how VMS+ evolves — from validation studies to discussions around scalability and workflow integration.
Your insight helps support sustainable, high-quality cardiac imaging.
Join the VMS+ Movement
Looking to enhance RV surveillance without increasing clinical burden?
- Request a Demo
– explore VMS+ in your own clinical environment - Share Your Experience
– your insights shape our roadmap - Connect With Us
– let’s advance cardiac care together
Let’s transform cardiac care together:
one patient, one insight, one workflow at a time.
Warm regards,
Matt Dobson,
Marketing Director
Ventripoint Diagnostics Ltd
The exercise described was conducted as an informal observational activity during AEPC 2026.
It was not a formal clinical study, and findings should be interpreted as illustrative of clinical practice rather than definitive evidence.
VMS+ is for trained Healthcare Professional use only.
Availability subject to regulatory approval in respective regions: please contact Ventripoint Diagnostics Ltd. for further information.
